tiprankstipranks
Advertisement
Advertisement

Psyence Partner GoldCoast Raises $8.6 Million, Clearing Key Merger Hurdle

Story Highlights
  • GoldCoast Resource raised about $8.6 million to fund exploration and working capital needs.
  • The financing satisfies a key condition for Psyence’s planned reverse takeover, though approvals remain pending.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Psyence Partner GoldCoast Raises $8.6 Million, Clearing Key Merger Hurdle

Claim 55% Off TipRanks

Psyence Group ( (TSE:PSYG) ) has shared an update.

Psyence Group said GoldCoast Resource Corp., its proposed reverse takeover partner, has closed a second non-brokered private placement tranche, issuing 3,280,140 shares at $0.85 each for $2.78 million in proceeds. Combined with a prior brokered tranche, the financing totals about $8.6 million to support GoldCoast’s exploration programs and working capital.

The successful completion of the financing fulfills a key condition for the planned amalgamation and Psyence’s change of business toward GoldCoast’s near-shore mineral exploration activities. However, the transaction still depends on multiple shareholder and regulatory approvals, including from the Canadian Securities Exchange, leaving the timing and outcome uncertain for investors and other stakeholders.

The most recent analyst rating on (TSE:PSYG) stock is a Sell with a C$0.11 price target. To see the full list of analyst forecasts on Psyence Group stock, see the TSE:PSYG Stock Forecast page.

Spark’s Take on PSYG Stock

According to Spark, TipRanks’ AI Analyst, PSYG is a Neutral.

The score is driven primarily by weak financial performance (no revenue, ongoing losses, and negative free cash flow), partially offset by an improved balance sheet (debt at 0 and equity positive). Technicals remain soft with the stock below key longer-term moving averages, and valuation is constrained by losses and no dividend. A recent RSU incentive program is a small positive but not a fundamental catalyst by itself.

To see Spark’s full report on PSYG stock, click here.

More about Psyence Group

Psyence Group Inc. is a life science biotechnology company focused on developing nature-derived psychedelic products, particularly psilocybin-based therapies, for mental health and wellness applications. The company is pursuing a reverse takeover of GoldCoast Resource Corp., which would pivot Psyence’s listed entity toward GoldCoast’s offshore gold exploration business in Ghana, pending required shareholder and regulatory approvals.

Technical Sentiment Signal: Strong Sell

Current Market Cap: C$1.88M

For an in-depth examination of PSYG stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1